High dose cabergoline in management of ovarian hyperstimulation syndrome
- 30 September 2009
- journal article
- case report
- Published by Elsevier BV in Fertility and Sterility
- Vol. 92 (3), 1168.e1-1168.e4
- https://doi.org/10.1016/j.fertnstert.2009.05.021
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Direct Binding of GTP Cyclohydrolase and Tyrosine HydroxylaseJournal of Biological Chemistry, 2008
- Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndromeHuman Reproduction Update, 2008
- Cabergoline reduces the early onset of ovarian hyperstimulation syndrome: a prospective randomized studyReproductive BioMedicine Online, 2008
- Dopamine Agonist Cabergoline Reduces Hemoconcentration and Ascites in Hyperstimulated Women Undergoing Assisted ReproductionJournal of Clinical Endocrinology & Metabolism, 2007
- Dopamine in vivo inhibits VEGF-induced phosphorylation of VEGFR-2, MAPK, and focal adhesion kinase in endothelial cellsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Tyroxine hydroxylase (TH) downregulation in hyperstimulated ovaries reveals the dopamine agonist bromocriptine (Br2) as an effective and specific method to block increased vascular permeability (VP) in OHSSFertility and Sterility, 2003
- The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factorNature Medicine, 2001
- Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transferFertility and Sterility, 2000
- Ovarian Hyperstimulation SyndromeObstetrical & Gynecological Survey, 1989
- THROMBOEMBOLIC PHENOMENA AFTER OVARIAN STIMULATION WITH HUMAN GONADOTROPHINSThe Lancet, 1965